Cite
HARVARD Citation
Pitman, J. et al. (n.d.). The ULK1 inhibitor ENV-201 impairs tumor growth in KRAS-driven flank xenografts as a single agent and in combination with the KRAS inhibitor adagrasib. European journal of cancer. pp. S34-S35. [Online].